Literature DB >> 15907291

A 1.3 kb promoter fragment confers spatial and temporal expression of utrophin A mRNA in mouse skeletal muscle fibers.

Mark A Stocksley1, Joe V Chakkalakal, Amanda Bradford, Pedro Miura, Yves De Repentigny, Rashmi Kothary, Bernard J Jasmin.   

Abstract

Upregulation of utrophin in muscle is currently being examined as a potential therapy for Duchenne muscular dystrophy patients. In this context, we generated transgenic mice harboring a 1.3 kb human utrophin A promoter fragment driving expression of the lacZ gene. Characterization of reporter expression during postnatal muscle development revealed that the levels and localization of beta-galactosidase parallel expression of utrophin A transcripts. Moreover, we noted that the utrophin A promoter is more active in slow soleus muscles. Additionally, expression of the reporter gene was regulated during muscle regeneration in a manner similar to utrophin A transcripts. Together, these results show that the utrophin A promoter-lacZ construct mirrors expression of utrophin A mRNAs indicating that this utrophin A promoter fragment confers temporal and spatial patterns of expression in skeletal muscle. This transgenic mouse will be valuable as an in vivo model for developing and testing molecules aimed at increasing utrophin A expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15907291     DOI: 10.1016/j.nmd.2005.03.008

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  6 in total

1.  A transgenic mouse model engineered to investigate human brain-derived neurotrophic factor in vivo.

Authors:  Fabrice Guillemot; Italina Cerutti; Charles Auffray; Marie-Dominique Devignes
Journal:  Transgenic Res       Date:  2007-01-16       Impact factor: 2.788

2.  Soluble Heparin Binding Epidermal Growth Factor-Like Growth Factor Is a Regulator of GALGT2 Expression and GALGT2-Dependent Muscle and Neuromuscular Phenotypes.

Authors:  Megan L Cramer; Rui Xu; Paul T Martin
Journal:  Mol Cell Biol       Date:  2019-06-27       Impact factor: 4.272

3.  Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice.

Authors:  Guy L Odom; Paul Gregorevic; James M Allen; Eric Finn; Jeffrey S Chamberlain
Journal:  Mol Ther       Date:  2008-07-29       Impact factor: 11.454

4.  UtroUp is a novel six zinc finger artificial transcription factor that recognises 18 base pairs of the utrophin promoter and efficiently drives utrophin upregulation.

Authors:  Annalisa Onori; Cinzia Pisani; Georgios Strimpakos; Lucia Monaco; Elisabetta Mattei; Claudio Passananti; Nicoletta Corbi
Journal:  BMC Mol Biol       Date:  2013-01-30       Impact factor: 2.946

5.  Modulation of utrophin A mRNA stability in fast versus slow muscles via an AU-rich element and calcineurin signaling.

Authors:  Joe V Chakkalakal; Pedro Miura; Guy Bélanger; Robin N Michel; Bernard J Jasmin
Journal:  Nucleic Acids Res       Date:  2007-12-15       Impact factor: 16.971

6.  Utrophin up-regulation by an artificial transcription factor in transgenic mice.

Authors:  Elisabetta Mattei; Nicoletta Corbi; Maria Grazia Di Certo; Georgios Strimpakos; Cinzia Severini; Annalisa Onori; Agata Desantis; Valentina Libri; Serena Buontempo; Aristide Floridi; Maurizio Fanciulli; Dilair Baban; Kay E Davies; Claudio Passananti
Journal:  PLoS One       Date:  2007-08-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.